Acesion Pharma ApS
Team Leader
Team Staff
About Acesion
Acesion Pharma is a Danish biotechnology firm founded in 2011 and headquartered in Copenhagen that focuses on developing safer, more effective drug therapies for atrial fibrillation (AF), the most common type of cardiac arrhythmia. Using a novel approach that targets small conductance ion channels to regulate heart rhythm, the company aims to create first-in-class treatments that improve on existing therapies, which often have limited efficacy and significant side effects. Acesion’s research is rooted in academic work from the University of Copenhagen and Neurosearch, and it has advanced clinical programs, including small conductance channel inhibitor candidates designed for both acute and chronic management of AF.
Manage Cookie Consent
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.